144 related articles for article (PubMed ID: 18416739)
1. Malignancy after heart transplantation: incidence, prognosis and risk factors.
Crespo-Leiro MG; Alonso-Pulpón L; Vázquez de Prada JA; Almenar L; Arizón JM; Brossa V; Delgado JF; Fernandez-Yañez J; Manito N; Rábago G; Lage E; Roig E; Diaz-Molina B; Pascual D; Muñiz J
Am J Transplant; 2008 May; 8(5):1031-9. PubMed ID: 18416739
[TBL] [Abstract][Full Text] [Related]
2. Influence of induction therapy, immunosuppressive regimen and anti-viral prophylaxis on development of lymphomas after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.
Crespo-Leiro MG; Alonso-Pulpón L; Arizón JM; Almenar L; Delgado JF; Palomo J; Manito N; Rábago G; Lage E; Diaz B; Roig E; Pascual D; Blasco T; de la Fuente L; Campreciós M; Vázquez de Prada JA; Muñiz J
J Heart Lung Transplant; 2007 Nov; 26(11):1105-9. PubMed ID: 18022075
[TBL] [Abstract][Full Text] [Related]
3. Cancer Incidence in Heart Transplant Recipients With Previous Neoplasia History.
Delgado JF; Alonso-Pulpón L; Mirabet S; Almenar L; Villa FP; González-Vílchez F; Palomo J; Blasco T; Dolores García-Cosio M; González-Costello J; de la Fuente L; Rábago G; Lage E; Pascual D; Molina BD; Arizón JM; Muñiz J; Crespo-Leiro MG
Am J Transplant; 2016 May; 16(5):1569-78. PubMed ID: 26613555
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Prognosis of Colorectal Cancer After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumor Registry.
Sagastagoitia-Fornie M; Morán-Fernández L; Blázquez-Bermejo Z; Díaz-Molina B; Gómez-Bueno M; Almenar-Bonet L; López-Granados A; González-Vílchez F; Mirabet-Pérez S; García-Romero E; Jose M SM; Rábago Juan-Aracil G; Castel-Lavilla MA; Blasco-Peiro T; Garrido-Bravo I; De La Fuente-Galán L; Muñiz J; Crespo-Leiro MG
Transpl Int; 2023; 36():11042. PubMed ID: 37275465
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer after heart transplantation: results from a large multicenter registry.
Crespo-Leiro MG; Villa-Arranz A; Manito-Lorite N; Paniagua-Martin MJ; Rábago G; Almenar-Bonet L; Alonso-Pulpón L; Mirabet-Pérez S; Diaz-Molina B; González-Vilchez F; Arizón de Prado JM; Romero-Rodriguez N; Delgado-Jimenez J; Roig E; Blasco-Peiró T; Pascual-Figal D; De la Fuente Galán L; Muñiz J
Am J Transplant; 2011 May; 11(5):1035-40. PubMed ID: 21521471
[TBL] [Abstract][Full Text] [Related]
6. Low Incidence of Malignancy After Heart Transplantation in Taiwan.
Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
Transplant Proc; 2016 Apr; 48(3):974-7. PubMed ID: 27234782
[TBL] [Abstract][Full Text] [Related]
7. Malignancy following heart transplantation: differences in incidence and prognosis between sexes - a multicenter cohort study.
Minguito-Carazo C; Gómez-Bueno M; Almenar-Bonet L; Barge-Caballero E; González-Vílchez F; Delgado-Jiménez JF; María Arizón Del Prado J; Sousa-Casasnovas I; Mirabet-Pérez S; González-Costello J; Sobrino-Márquez JM; Pérez-Villa F; Díaz-Molina B; Rábago Juan-Aracil G; Blasco-Peiró T; De la Fuente Galán L; Garrido-Bravo I; García-Guereta L; Camino M; Albert-Brotons DC; Muñiz J; Crespo-Leiro MG
Transpl Int; 2021 May; 34(5):882-893. PubMed ID: 33482021
[TBL] [Abstract][Full Text] [Related]
8. Malignancy after heart transplantation: analysis of 24-year experience at a single center.
Yagdi T; Sharples L; Tsui S; Large S; Parameshwar J
J Card Surg; 2009; 24(5):572-9. PubMed ID: 19486222
[TBL] [Abstract][Full Text] [Related]
9. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
[TBL] [Abstract][Full Text] [Related]
10. Cancer After Heart Transplantation: A 25-year Single-center Perspective.
Van Keer J; Droogné W; Van Cleemput J; Vörös G; Rega F; Meyns B; Janssens S; Vanhaecke J
Transplant Proc; 2016; 48(6):2172-7. PubMed ID: 27569966
[TBL] [Abstract][Full Text] [Related]
11. The falling incidence of hematologic cancer after heart transplantation.
Crespo-Leiro MG; Delgado-Jiménez J; López L; Alonso-Pulpón L; González-Vilchez F; Almenar-Bonet L; Rábago G; Pérez-Villa F; Paniagua Martín MJ; Arizón Del Prado JM; Sousa-Casasnovas I; Manito-Lorite N; Díaz-Molina B; Pascual-Figal D; Lage-Galle E; Blasco-Peiró T; De la Fuente-Galán L; Muñiz J
Clin Transplant; 2014 Oct; 28(10):1142-7. PubMed ID: 25100534
[TBL] [Abstract][Full Text] [Related]
12. Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: effect of preemptive therapy.
Mendez-Eirin E; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Grille-Cancela Z; Cañizares A; Naya-Leira C; Gargallo-Fernández P; Castro-Beiras A; Crespo-Leiro M
Transplant Proc; 2012 Nov; 44(9):2660-2. PubMed ID: 23146486
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for herpes zoster following heart transplantation.
Koo S; Gagne LS; Lee P; Pratibhu PP; James LM; Givertz MM; Marty FM
Transpl Infect Dis; 2014 Feb; 16(1):17-25. PubMed ID: 24147978
[TBL] [Abstract][Full Text] [Related]
14. Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression.
Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
Transplant Proc; 2016 Apr; 48(3):969-73. PubMed ID: 27234781
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after ABO-incompatible heart transplantation in adults: A registry study.
Bergenfeldt H; Andersson B; Bućin D; Stehlik J; Edwards L; Rådegran G; Nilsson J
J Heart Lung Transplant; 2015 Jul; 34(7):892-8. PubMed ID: 25754241
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prognosis of cancer following heart transplantation using RATG induction therapy.
El-Hamamsy I; Stevens LM; Carrier M; Pelletier G; White M; Tremblay F; Perrault LP
Transpl Int; 2005 Nov; 18(11):1280-5. PubMed ID: 16221159
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors.
Alvarez-Alvarez RJ; Barge-Caballero E; Chavez-Leal SA; Paniagua-Martin MJ; Marzoa-Rivas R; Caamaño CB; López-Sainz Á; Grille-Cancela Z; Blanco-Canosa P; Herrera-Noreña JM; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
J Heart Lung Transplant; 2015 Feb; 34(2):167-74. PubMed ID: 25434523
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of heart transplantation in patients with human immunodeficiency virus.
Madan S; Patel SR; Saeed O; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
Am J Transplant; 2019 May; 19(5):1529-1535. PubMed ID: 30614612
[TBL] [Abstract][Full Text] [Related]
19. Hypotension, acidosis and vasodilation syndrome after heart transplant: incidence, risk factors, and prognosis.
Paniagua MJ; Crespo-Leiro MG; Muñiz J; Vázquez E; Tabuyo T; Castro-Orjales M; Fojon S; López JM; Garrido IP; Juffé A; Castro-Beiras A
Transplant Proc; 2003 Aug; 35(5):1957-8. PubMed ID: 12962862
[TBL] [Abstract][Full Text] [Related]
20. Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation Registry.
Katz M; Freimark D; Raichlin E; Har-Zahav Y; Arad M; Kassif Y; Peled A; Asher E; Elian D; Kogan A; Shlomo N; Ofek E; Lavee J; Goldenberg I; Peled Y
Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28753240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
